The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Effect of cholesterol and triglyceride increases on time to progression in renal clear cell cancer patients treated with everolimus.
Francesco Pantano
No relevant relationships to disclose
Giuseppe Procopio
No relevant relationships to disclose
Marianna Silletta
No relevant relationships to disclose
Cinzia Ortega
No relevant relationships to disclose
Francesco Maria Guida
No relevant relationships to disclose
Olga Venditti
No relevant relationships to disclose
Veronica Prati
No relevant relationships to disclose
Marco Imperatori
No relevant relationships to disclose
Chiara Spoto
No relevant relationships to disclose
Elena Verzoni
No relevant relationships to disclose
Salvatore Intagliata
No relevant relationships to disclose
Bruno Vincenzi
No relevant relationships to disclose
Giuseppe Tonini
No relevant relationships to disclose
Mimma Rizzo
No relevant relationships to disclose
Daniele Santini
No relevant relationships to disclose